Author: Dr Val Phua
Estimated reading time: 10–12 minutes
Atropine Eye Drops Are One of the Most Effective Ways to Slow Childhood Myopia
If your child has recently become short-sighted (myopic), you may have been told that atropine eye drops can help slow the progression of their myopia.
Many parents are surprised to learn that the aim of atropine treatment is not to improve vision or eliminate the need for glasses, but rather to slow the growth of the eye and reduce the risk of developing high myopia later in life.
Today, low-dose atropine is one of the most widely studied and commonly prescribed treatments for childhood myopia control.
What Is Atropine?
Atropine is a medication that has been used safely in ophthalmology for many decades.
At higher concentrations, atropine has traditionally been used to:
- Dilate the pupil
- Relax the eye’s focusing muscles
- Treat certain inflammatory eye conditions
For myopia control, however, very low concentrations are used. These lower doses have minimal effects on the pupil and focusing ability while helping to slow the progression of myopia.
How Does Atropine Slow Myopia?
Scientists are still studying the exact mechanism, but atropine is thought to influence biochemical pathways within the retina and sclera (the white outer layer of the eye) that regulate eye growth.
Instead of simply relaxing the focusing muscles, low-dose atropine appears to reduce the signals that stimulate excessive elongation of the eyeball.
Because the eye grows more slowly, myopia tends to progress at a slower rate.
Who Should Consider Atropine Eye Drops?
Atropine may be recommended for children who:
- Have recently developed myopia
- Are becoming more short-sighted each year
- Developed myopia at a young age
- Have one or both parents with high myopia
- Are at increased risk of progressing to high myopia
Treatment decisions are individualised and depend on factors such as age, prescription, rate of progression and lifestyle.
How Are Atropine Eye Drops Used?
Low-dose atropine is usually:
- Instilled once every night
- Continued for several years while the eyes are still growing
- Combined with regular eye examinations to monitor progress
Parents should wash their hands before administering the drops and avoid touching the tip of the bottle to the eye or eyelashes.
How Effective Is Atropine?
Large clinical studies have consistently shown that low-dose atropine can slow the progression of childhood myopia, although the degree of benefit varies between individuals.
The goal is to reduce the rate at which myopia worsens—not to stop progression completely.
Children often still require updated spectacles as they grow, but the changes may occur more slowly.
Are Atropine Eye Drops Safe?
Yes.
Low-dose atropine has been extensively studied and is generally well tolerated.
Most children experience few or no side effects when appropriate low concentrations are used.
Regular follow-up remains important to monitor both treatment response and eye health.
Possible Side Effects
Although uncommon at low concentrations, side effects may include:
- Mild light sensitivity
- Slight enlargement of the pupil
- Mild difficulty focusing on near objects
- Temporary stinging after instillation
- Allergic reactions (rare)
Most side effects improve as the concentration decreases.
If significant symptoms occur, your ophthalmologist may adjust the treatment.
How Long Will My Child Need Treatment?
Myopia usually progresses throughout childhood and slows naturally in the late teenage years.
Many children remain on atropine treatment until they are mid teens (15-16 years old), although the duration varies depending on:
- Age
- Rate of progression
- Response to treatment
- Family history
Treatment should not be stopped without medical advice.
What Happens If Atropine Is Stopped?
Some children experience rebound progression, where myopia begins increasing more rapidly after treatment is discontinued.
The risk appears to be lower with lower concentrations of atropine.
Your ophthalmologist may recommend tapering treatment or continuing therapy for longer if progression remains active.
Can Atropine Be Combined with Other Treatments?
Yes.
Some children benefit from combination therapy, such as:
- Atropine plus orthokeratology (Ortho-K)
- Atropine plus defocus spectacle lenses
- Atropine together with healthy lifestyle measures
Combination treatment may be considered for children with rapidly progressing myopia.
Frequently Asked Questions
Will atropine improve my child’s eyesight?
No.
Atropine slows myopia progression but does not reverse existing myopia or eliminate the need for glasses.
Will my child become dependent on atropine?
No.
The drops do not cause dependence. They are used while the eyes are actively growing and are discontinued when treatment is no longer needed.
Are atropine eye drops painful?
Most children experience little or no discomfort. A brief stinging sensation may occur when the drops are instilled.
Is atropine safe for long-term use?
Current evidence supports the safety of low-dose atropine when used under the supervision of an ophthalmologist with regular follow-up.
The Bottom Line
Low-dose atropine eye drops are one of the most effective and well-studied treatments available for slowing childhood myopia progression. They work by reducing excessive eye growth, helping to lower the risk of developing high myopia and its associated complications later in life.
When combined with regular eye examinations, healthy visual habits and increased outdoor time, atropine forms an important part of modern myopia management. Every child is different, so treatment should always be individualised after a comprehensive eye assessment.
References
- International Myopia Institute. IMI Clinical Management Guidelines.
- Singapore Eye Research Institute. ATOM (Atropine for the Treatment of Myopia) Studies.
- American Academy of Ophthalmology. Childhood Myopia and Atropine Therapy.
- World Society of Paediatric Ophthalmology and Strabismus. Consensus Statement on Myopia Management.
- Chia A, et al. ATOM1 and ATOM2 Studies. Landmark clinical trials evaluating atropine for childhood myopia control.
